摘要
目的:观察低分子肝素在治疗心绞痛中临床疗效及不良反应。方法:选择心绞痛住院患者84例,随机平分成两组:对照组给予常规抗心绞痛治疗:治疗组给予常抗心绞痛治疗同时加低分子肝素钙。结果:运用低分子肝素治疗心绞痛的疗效明显优于对照组,未出现出血、局部或全身过敏、低分子肝素诱导的血小板减少症等严重不良反应。结论:采用低分子肝素治疗心绞痛疗效好,副作用低,使用安全、方便,患者易于接受,在临床上值得推广使用。
Objective：To observe the low molecular weight heparin in the treatment of angina in clinical efficacy and side effects.Methods：84 cases of amgina patients,randomly divided into two groups：control group given conventional anti-angina treatment：the treatment group to give regular anti-angina treatment at the same time to increase low-molecular-weight heparin.Results：The use of low-molecular -weight heparin in the treatment of angina pectoris better than the control group,no bleeding ,local or systmic allergy,low molecular weight heparin-induced thrombocytopenis such as severe adverse reactions：Concluson：The use of low-molecular-weight heparin in the treatment of angina pectoris,and low side effects,the use of safe,convenient,easy-to-accept patients in clinical use should be promoted.
出处
《中国医药导刊》
2008年第8期1199-1199,1203,共2页
Chinese Journal of Medicinal Guide
关键词
肝素
低分子量
心绞痛
临床疗效
不良反应
heparin
low-molecular-weight
angina pectoris
clinical efficacy
adverse reactions
